trial · primary record
Upadacitinib
Non-Segmental Vitiligo
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 154 |
| Primary completion | 2032-08 |
| Primary endpoint | Percentage of Participants Achieving Facial-Vitiligo Area Scoring Index (F-VASI) 75 (>= 75% Improvement in F-VASI From Baseline) |
| Registry ID | NCT07896434 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:17.144Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07896434
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.